41 results on '"Cianferoni, Antonella"'
Search Results
2. New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting
3. Dupilumab Is Efficacious Up To 52 Weeks In Patients With Eosinophilic Esophagitis Irrespective Of Prior Food Elimination Diet Or History Of Food Allergy
4. New diagnosis of Eosinophilic Esophagitis (EoE) in patients undergoing Oral immunotherapy (OIT): a retrospective review of real-world Multi-foods or single-food OIT in 788 children and young adults
5. A genome-wide association meta-analysis identifies new eosinophilic esophagitis loci
6. Baseline Characteristics of Patients Who Fail Low-Dose Challenges and Patients Who Reach Maintenance OIT to Cashew
7. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
8. Effect of Dupilumab on Eosinophilic Esophagitis when used for other approved indications
9. Non–IgE-mediated anaphylaxis
10. Safety review of Year 1 Oral Immunotherapy Clinic: Multifood Immunotherapy in Real-World setting
11. The impact of COVID-19 on patients with food protein-induced enterocolitis syndrome (FPIES) and their caregivers.
12. Budesonide Oral Suspension Improves Histologic Features In Patients With Eosinophilic Esophagitis: Results From A Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
13. Identification of potential CD4+ T-cell pathways associated with epicutaneous milk desensitization of eosinophilic esophagitis patients
14. Food protein–induced enterocolitis syndrome in the US population–based study
15. Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α
16. Double-Blind, Placebo-Controlled Randomized Trial of Epicutaneous Immunotherapy in Children of Milk-Induced Eosinophilic Esophagitis
17. Cost-effectiveness of Implementing a Pediatric Anaphylaxis Algorithm
18. A population-based study of FPIES prevalence among US children
19. Food Protein-Induced Enterocolitis Syndrome Food Challenges: The Children’s Hospital of Philadelphia Experience
20. A COMPARISON OF COMORBID DIAGNOSES IN CHILDREN WITH AND WITHOUT EOSINOPHILIC ESOPHAGITIS IN A LARGE PRIMARY CARE POPULATION
21. International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology
22. Omalizumab facilitates rapid oral desensitization for peanut allergy
23. At-home Dosing Adherence During Characterized Oral Desensitization Immunotherapy (CODIT) for Peanut Allergy
24. Children With Tolerance Of Baked Egg Demonstrate Higher Eliciting Doses In Challenges To Native Egg
25. Outgrowing eosinophilic esophagitis: it is possible
26. Life after Peanut Immunotherapy
27. Differences in CD4IL-17+ in Children and Adults with Eosinophilic Esophagitis
28. The Efficacy of AR101, a Peanut-Derived Pharmaceutical for Oral Immunotherapy (OIT), Is Maintained and Tolerability Is Increased with Low-Dose Maintenance Therapy
29. A Review of Food Challenges Performed on Children with Large Skin Prick Tests
30. Omalizumab Facilitates Rapid Oral Desensitization for Peanut Allergy
31. Resolution of acute IgE-mediated allergy with development of eosinophilic esophagitis triggered by the same food
32. Older Mice Intranasally Sensitized with Aspergillus Fumigatus Develop Stronger Eosinophilic Esophageal Inflammation Compared to Their Younger Counterparts
33. Prevalence Of Food Allergy To Uncommon Foods Based On Oral Food Challenges
34. Prevalence of Pediatric Drug Allergy Based On Drug Provocation Testing
35. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet
36. Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin
37. Atopy and allergic respiratory diseases in multitransfused patients: A new insight into the increase in the prevalence of atopy
38. Selective expression of nuclear factor of activated T cells 2/c1 in human basophils: Evidence for involvement in IgE-mediated IL-4 generation
39. Histone deacetylation inhibits IL4 gene expression in T cells
40. Prevalence and risk factors of latex sensitization in an unselected pediatric population☆☆☆★
41. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.